2024 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2023 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2022 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2021 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2020 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2019 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2016 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2015 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded

2014 21 CFR 330.14 – Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded